GWPH recently raised total net proceeds after expenses of approximately $118 million from a U.S. public offering of American Depositary Shares (ADSs) on the NASDAQ Global Market GWPHâs preparations for Phase 3 clinical trials in both Dravet and Lennox .. ...
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home